Raymond James & Associates’s Delek US DK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-18,300
Closed -$1K 3579
2018
Q3
$1K Sell
18,300
-700
-4% -$34.5K ﹤0.01% 3626
2018
Q2
$6K Buy
+19,000
New +$945K ﹤0.01% 3539

Other funds holding DK

Raymond James & Associates's DK Position: Q3 2024 in Review

Raymond James & Associates reduced its Delek US (DK) stake by 3.4% in Q3 2024, selling an estimated $365K and leaving 486,875 shares worth $9.13M. The position accounts for 0.01% of the portfolio, ranked #1279.

Raymond James & Associates first reported a position in DK in Q2 2017 and has held it in 18 quarters since. The position peaked at $16M in Q1 2024. 213 funds tracked by Wall St. Rank hold DK as of Q3 2024.

  • Raymond James & Associates held 486,875 shares of Delek US worth $9.13M as of Q3 2024.
  • Raymond James & Associates sold 17,251 Delek US shares in Q3 2024, an estimated $365K.
  • Delek US made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1279 holding.
  • Raymond James & Associates first reported a position in Delek US in Q2 2017 and has held it in 18 quarters since.
  • Raymond James & Associates's Delek US position peaked at $16M in Q1 2024.
  • 213 funds tracked by Wall St. Rank held Delek US as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.